Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

More than 2.5M gained health coverage during special open enrollment

A special enrollment period implemented by the Biden administration saw more than 2.5 million people sign up for health insurance.

 

Thumbnail

Medicare improves racial healthcare inequities

Medicare is associated with reductions in racial and ethnic disparities in insurance coverage, access to care and self-reported health across the U.S., according to a new study published in JAMA.

 

Thumbnail

Healthcare system still suing patients after being sold

A healthcare system in Tennessee is still suing patients for uncollected debt even after it’s been sold and some of its facilities were repurposed by the buyer. 

healthcare value value-based care money dollar

Only 5.6% of hospitals comply with price transparency rule

The vast majority of hospitals are not following through on a recent requirement to publish their list prices online, according to a recent study from PatientRightsAdvocate.com.

 

Thumbnail

CMS may charge hospitals for not posting prices online

The Centers for Medicare and Medicaid Services has proposed charging hospitals that fail to post their list prices online as required. 

 

Thumbnail

Johnson & Johnson settles opioid case with New York for $230M

Johnson & Johnson will pay New York State $230 million in a settlement over a lawsuit against the drug manufacturer for its role in the opioid epidemic. 

 

LGBTQ care lesbian gay rainbow

Biden administration reverses Trump-era healthcare discrimination rule

The Department of Health and Human Services has overturned a Trump-era rule that would have allowed healthcare providers to discriminate against patients based on sexual orientation or gender identity. 

 

Biden administration waives protections for COVID-19 vaccines

The Biden administration has backed the waiving of intellectual property protections for COVID-19 vaccines, supporting a proposal from the World Trade Organization to improve worldwide vaccinations against the deadly virus.

 

Displaying 745 - 752 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.